Search Results

Novel therapeutic strategies to improve the outcomes of patients with myeloproliferative neoplasms

The identification of critical therapeutic targets in myeloproliferative neoplasm (MPN) cells will have a significant impact on the development of muc…

Targeting TLR9 Signaling to restore immunomodulating function of FRCs in Richter's Transformation

Richter’s transformation (RT) refers to the development of an aggressive lymphoma in patients with a prior diagnosis of chronic lymphocytic leukemia (…

Communities Nationwide Are Stepping Up to Help Patients Live Longer Better Lives

WASHINGTON, February , – The Leukemia & Lymphoma Society’s (LLS)’s fundraising event, Big Climb officially kicks off nationwide on February and will…

Medicaid is a lifesaver for blood cancer patients: We need to protect it

Breakthrough treatments are transforming what it means to receive a blood cancer diagnosis for hundreds of thousands of people across the country, giv…

Blood Cancer United Welcomes Three New Members to its Board of Directors

New Members Bring Extensive Expertise in Science, Drug Development & Legal Counsel to the Global Leader in Creating a World Without Blood Cancer …

Making the Right Choice: Medicare Plan Selection and Access to Cancer Care

Selecting a Medicare plan is a and complex decision with substantial financial implications, particularly for individuals with cancer. The proposed p…

FDA Approves New Type of BTK Inhibitor to Treat Mantle Cell Lymphoma

The U.S. Food and Drug Administration today approved pirtobrutinib (Jaypirca™), the first , reversable BTK inhibitor for the treatment of adults with …

Fecal microbiota transplantation to prevent acute GVHD after allogeneic stem cell transplantation

In up to half of patients with hematologic malignancies undergoing allogeneic stem cell transplantation, the trajectory of a smooth recovery toward cu…

Strategic combinations to overcome therapeutic resistance and relapse in acute myeloid leukemia

Acute myeloid leukemia (AML) is the most fatal type of leukemia and has a high rate of relapse following current therapies. We have recently uncovered…

THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) INVESTS $3.8 MILLION TO ADVANCE HEALTH EQUITY

LLS’s Equity in Access Research Program Awards Five New Grants to Researchers Across the U.S. Aiming to Break Down Barriers to Care for Blood Cancer P…

37 Patient Organizations Applaud Proposed Rule to Rein in Short-Term Health Plans

health plans don’t offer typical health insurance benefits and don’t include consumer protections such as coverage for conditions, elimination of ann…

Defining mechanisms of sensitivity and resistance to PI3K gamma inhibition in AML

The goal of our laboratory is to discover, study, and the translate new leukemia therapies to the clinic. In this project, we are studying a signaling…

Suggested Reading - It's Not About the Bike: My Journey Back to Life

This is the story of a journey from inauspicious beginnings through triumph, tragedy, transformation and transcendence. It is the personal story of La…

Suggested Reading - When a Parent Has Cancer: A Guide to Caring for Your Children

Advice for parents who are raising children while at the same time coping with a illness. Includes a special book for children: Becky and the Worry C…

Suggested Reading - One Hundred Days: My Unexpected Journey from Doctor to Patient

Stricken with a potentially rare blood disease, Dr. Biro chooses to undergo a potentially curative, though potentially allogeneic stem cell transpla…

LLS Community Guide: Joining groups to see disease and topic specific content​

New Drug Approval Moves Us Closer To Long-Term Control of Multiple Myeloma

Ciltacabtagene Autoleucel () is the second approved to treat multiple myeloma Just one year after the fir…

The Leukemia & Lymphoma Society Applauds Bipartisan Agreement to Stop Surprise Medical Bills

Patients are now one step closer to breathing a sigh of relief. For too long, they’ve faced the anxiety of knowing that any visit to a healthcare prov…

Diagnosed with a Blood Cancer? Important Questions You Might Not Think to Ask

What is my actual diagnosis? Find out your exact diagnosis. Ask your doctor to write down the exact name of your and take the paper with you. For exa…

Suggested Reading - Frankly Speaking About Cancer: Myelofibrosis

This booklet is designed to help you take more control over your situation and your treatment decisions by giving you a better understanding of what m…

Tatijane

On February , , I was diagnosed with acute lymphoblastic leukemia (ALL), both B and T cells, and given six to eight weeks to live. I was years old. I…

Rebecca

Everything happens for a reason and our pain is not for vain. Hi, my name is Rebecca Yanez, I am years old and a 2x acute lymphoblastic leukemia surv…

Angel Flight Northeast

To arrange free air and ground transportation so children and adults may access medical care This organization provides free flights in privat…

SAMHSA's National Helpline

To provide a free and confidential information service for individuals and family members facing mental and/or substance use disorders. The Subs…

Karina

Our daughter, Kiahura (Rara), was diagnosed with acute myeloid leukemia (AML) at a very young age, a moment that completely changed our family’s life.…